ES2036006T3 - Empleo de medicamentos con contenido de ifn-gamma para la prevencion y el tratamiento de enfermedades producidas por defectos inmunologicos primarios. - Google Patents

Empleo de medicamentos con contenido de ifn-gamma para la prevencion y el tratamiento de enfermedades producidas por defectos inmunologicos primarios.

Info

Publication number
ES2036006T3
ES2036006T3 ES198989115547T ES89115547T ES2036006T3 ES 2036006 T3 ES2036006 T3 ES 2036006T3 ES 198989115547 T ES198989115547 T ES 198989115547T ES 89115547 T ES89115547 T ES 89115547T ES 2036006 T3 ES2036006 T3 ES 2036006T3
Authority
ES
Spain
Prior art keywords
prevention
treatment
ifn
medicines
immunological defects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989115547T
Other languages
English (en)
Inventor
Anders Dr. Department Of Pediatrics Fasth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6361762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2036006(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2036006T3 publication Critical patent/ES2036006T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing Of Color Television Signals (AREA)
  • Picture Signal Circuits (AREA)

Abstract

ESTE INVENTO CONSISTE EN UN MEDICAMENTO QUE CONTIENE INTERFERON GAMMA (IFNGAMMA) PARA LA PREVENCION Y TRATAMIENTO DE ENFERMEDADES OCASIONADAS POR DEFECTOS PRIMARIOS DE INMUNIDAD. EL MEDICAMENTO ES ESPECIALMENTE ADECUADO PARA ENFERMEDADES QUE PUEDEN APARECER, REGULAR O ESPORADICAMENTE, A CAUSA DE UNA "INMUNODEFICIENCIA DE COMBINACION DIFICIL (SCID)".
ES198989115547T 1988-08-29 1989-08-23 Empleo de medicamentos con contenido de ifn-gamma para la prevencion y el tratamiento de enfermedades producidas por defectos inmunologicos primarios. Expired - Lifetime ES2036006T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3829180A DE3829180A1 (de) 1988-08-29 1988-08-29 Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten

Publications (1)

Publication Number Publication Date
ES2036006T3 true ES2036006T3 (es) 1993-05-01

Family

ID=6361762

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989115547T Expired - Lifetime ES2036006T3 (es) 1988-08-29 1989-08-23 Empleo de medicamentos con contenido de ifn-gamma para la prevencion y el tratamiento de enfermedades producidas por defectos inmunologicos primarios.

Country Status (7)

Country Link
EP (1) EP0356900B1 (es)
JP (1) JP2766331B2 (es)
AT (1) ATE82685T1 (es)
CA (1) CA1332222C (es)
DE (2) DE3829180A1 (es)
ES (1) ES2036006T3 (es)
GR (1) GR3006713T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437868A1 (de) * 1994-10-22 1996-04-25 Boehringer Ingelheim Int Behandlung von HLA-DR-assoziierter Immundefizienz mit Interferon-gamma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−ｒポリペプチド誘導体
DE3536939A1 (de) * 1985-10-17 1987-04-23 Hoechst Ag Biologisch aktive derivate des human-(gamma)-interferons, ihre herstellung und arzneimittel, die solche derivate enthalten
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma

Also Published As

Publication number Publication date
JPH02111730A (ja) 1990-04-24
EP0356900A2 (de) 1990-03-07
EP0356900B1 (de) 1992-11-25
EP0356900A3 (en) 1990-10-10
CA1332222C (en) 1994-10-04
DE3829180A1 (de) 1990-03-08
JP2766331B2 (ja) 1998-06-18
DE58902815D1 (de) 1993-01-07
GR3006713T3 (es) 1993-06-30
ATE82685T1 (de) 1992-12-15

Similar Documents

Publication Publication Date Title
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ATE97570T1 (de) Arzneimittel zur verhuetung von sexuell uebertragbaren krankheiten.
MX9203328A (es) Complejo de interferon de zinc-protamina-alfa.
FI862011A (fi) Terapeutiska nukleosider.
NO933293D0 (no) (s)-(+)-hydroksyklorin og anvendelse derav for fremstilling av legemidler
DE59409604D1 (de) Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
GR3026369T3 (en) Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist.
NO870441D0 (no) Farmasoeytiske preparatformer for stabilisering av alfa- interferon.
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
DE3566404D1 (en) Substituted benzopyrans, process for their preparation and their use in medicines
IL99077A0 (en) New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
ES2036006T3 (es) Empleo de medicamentos con contenido de ifn-gamma para la prevencion y el tratamiento de enfermedades producidas por defectos inmunologicos primarios.
AU7806187A (en) Sulphonamide derivatives for the treatment and prevention of viral diseases
ES2049711T3 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de cistinuria.
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
IL84550A (en) Pharmaceutical compositions for treatment of viral infections containing 3( -fluoro-3(-deoxy-thymidine
EP0271447A3 (en) Preventive measures for preventing the "bovine complex respiratory disease" by administering interferon
ZA919682B (en) Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
LTIP472A (en) Composition for the treatment of infection and disease caused by hepatit b virus
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.
FR2668065B1 (fr) Composition pharmaceutique destinee au traitement et a la prevention des infections retrovirales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 356900

Country of ref document: ES